Rare Disease Report

Tim Tebow and Others Send Rare Cancer Patient Motivational Messages

JANUARY 23, 2017
Andrew Black
Ryan Teixeira is doing all that he can to stay positive and fight through his rare cancer. Soon after signing a scholarship to play baseball for Colorado Mesa University, he was diagnosed with acute myeloid leukemia (AML).  With this being his second cancer diagnosis (the first being Ewing’s sarcoma), the young baseball player is making sure he stays positive, and it definitely helps when you receive an inspiring messages Tim Tebow and other professional baseball players.
Tim Tebow, once football now baseball player, joined in with thousands of others who are posting to Ryan’s Facebook, doing their part in helping him continue his fight. Recently, Tim left Ryan a personalized video on his page to provide motivation support on his battle with cancer (see below).
Tebow isn’t the only pro athlete that has had something. Ryan has received uplifting messages and visits from other baseball stars, such as Los Angeles Dodgers' manager Dave Roberts, infielder Justin Turner, and first baseman Adrian Gonzalez.
Ryan is confident that he will beat his cancer, and Colorado Mesa University believes him as well as they holding his scholarship until he is healthy and ready to play.

About Acute Myeloid Leukemia (AML)

AML arises from the myeloid cells that serve as precursors to other types of blood cells. These cancer cells originate in the bone marrow and quickly spread through the bloodstream. The cancer cells crowd out normal blood cell cells, leading to reduced number of red blood cells, white blood cells, and platelets. This causes symptoms like fatigue, increased risk of infection, and bleeding.
Without treatment, the aggressive cancer progresses rapidly. Many patients receive intensive chemotherapy to kill the cancerous blood cells and a later stem cell transplant from a donor. 

About Ewing Sarcoma

Ewing sarcoma is a rare cancer that afflicts the bone. Most cases occur in the young with 90% of Ewing sarcoma patients being between the ages of 5 and 25 years. There are 600-800 new cases diagnosed each year in the United States and the 5-year survival rate for patients with localized disease is approximately 75% and about 30% for those who have seen the cancer metastasize.
Treatment of Ewing’s sarcoma varies per person and tumor location but often includes chemotherapy (eg, doxorubicin, vincristine, cyclophosphamide, dactinomycin, ifosfamide, and/or etoposide) in combination with surgical procedures and/or radiation. There are currently no approved orphan drugs for this rare condition.

Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.